Skip to content
ClosedNo longer accepting applications

Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) - TA4

DEPT OF DEFENSE

About this archived opportunity

The Defense Advanced Research Projects Agency (DARPA) is seeking support for commercialization of technologies to be developed under the upcoming Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) program. The purpose of this announcement is to notify the community of the RAPIID commercialization goals, initiate dialogue to address program needs, and share the timetable for full proposal submission. This special notice is released under the current DARPA BTO Office Wide Broad Agency Announcement (BAA) HR001126S0003, titled �Biological Technologies.�

Historical details

Status
Closed
Deadline
June 29, 2026
First captured
June 12, 2026
Publisher reference
61a78b0d91244a65b239a1248a80e7af

This opportunity has closed

Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) - TA4

by DEPT OF DEFENSE

Get notified when similar opportunities open

We'll save this search and email you when new resuscitation, prevention, ischemia opportunities are posted. Free.

Refine this search